4.5 Review

Celebration of a century of insulin therapy in children with type 1 diabetes

Related references

Note: Only part of the references are listed.
Editorial Material Endocrinology & Metabolism

Racial and Socioeconomic Disparities in Pediatric Type 1 Diabetes: Time for a Paradigm Shift in Approach

Terri H. Lipman et al.

DIABETES CARE (2021)

Article Chemistry, Medicinal

Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans

Thomas B. Kjeldsen et al.

Summary: The molecular engineering of insulin icodec has resulted in a plasma half-life of 196 hours in humans, suitable for once-weekly subcutaneous administration. In a phase-2 clinical trial, it demonstrated safe and efficacious glycemic control comparable to once-daily insulin glargine in type 2 diabetes patients, showing the potential of insulin icodec as a long-acting therapeutic option.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Multidisciplinary Sciences

Strategies for durable β cell replacement in type 1 diabetes

Todd M. Brusko et al.

Summary: Advancements in blood glucose monitoring and therapeutic insulin administration have improved the quality of life for individuals with type 1 diabetes, but still fall short of the metabolic control provided by native islets. Integrated advancements in islet cell replacement and immunomodulatory therapies are offering hope for the restoration of endogenous glucose regulation. Progress in stem cell biology and graft site design are providing innovative sources for cellular material and improved engraftment.

SCIENCE (2021)

Review Multidisciplinary Sciences

Type 1 diabetes glycemic management: Insulin therapy, glucose monitoring, and automation

Bruce A. Perkins et al.

Summary: Despite innovations in insulin therapy, most type 1 diabetes patients still struggle to achieve sufficient glycemic control. The future may lie in combining pharmacological solutions with automated insulin delivery methods, utilizing machine learning and other technologies to enhance effectiveness.

SCIENCE (2021)

Review Endocrinology & Metabolism

The Evolution of Insulin and How it Informs Therapy and Treatment Choices

Irl B. Hirsch et al.

ENDOCRINE REVIEWS (2020)

Review Endocrinology & Metabolism

Review: Glucose-sensitive insulin

Thomas Hoeg-Jensen

MOLECULAR METABOLISM (2020)

Review Biochemistry & Molecular Biology

Glycemic Status Assessment by the Latest Glucose Monitoring Technologies

Ilaria Malandrucco et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Medicine, General & Internal

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

Kevan C. Herold et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Endocrinology & Metabolism

Dorothy Hodgkin Lecture 2013* Artificial Pancreas Project at Cambridge 2013

R. Hovorka

DIABETIC MEDICINE (2015)

Review Endocrinology & Metabolism

Hepatoselectivity and the evolution of insulin

R. Herring et al.

DIABETES OBESITY & METABOLISM (2014)

Editorial Material Public, Environmental & Occupational Health

Diabetes Mellitus: Its differentiation into insulin-sensitive and insulin-insensitive types

H. P. Himsworth

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2013)

Review Pharmacology & Pharmacy

A review of 20 years' experience with the Novopen (R) family of insulin injection devices

Jorn Rex et al.

CLINICAL DRUG INVESTIGATION (2006)